Stock Price & Analysis

Based on the analysis of UHS stock, considering both technical and fundamental factors, here is the concise recommendation:

Buy UHS Stock. The stock shows bullish price action and strong Q4 results, with core guidance exceeding estimates. However, be cautious of sector trends and mixed analyst sentiment.

Price Prediction for UHS Stock in 2025

Based on current trends and analysis, UHS stock is expected to reach $185-$190 by the end of 2025. This prediction is supported by the stock's oversold condition, with the RSI_14 at 42.48 and improving MACD signals, suggesting a potential rebound. Additionally, the stock's valuation and recent positive earnings momentum, despite short-term volatility, align with this target range.

The S1 support level for UHS Stock is $164.77 ,The R1 resistant level for UHS Stock is $177.88.

As of the end of day on 2025-03-17, the price of UHS Stock was $167.37.

The target price for UHS Stock according to analyst rating is 231.22, with the highest price target at 267.00 and the lowest at 198.00. Analysts have a Moderate Buy rating on UHS Stock overall.

The market cap of UHS is $10.9B.

UHS is fairly valued based on current metrics. Its P/E ratio of 12.5x is below the industry average, and EV/EBITDA of 8.3x aligns with peers. Steady revenue growth and improving margins support its valuation. Analysts maintain a $223 average price target, indicating 27% upside potential. Regulatory risks remain a concern, but overall, UHS appears reasonably priced with growth potential.

Universal Health Services, Inc. is a holding company. It operates through its subsidiaries, including its management company. It is engaged in owning and operating acute care hospitals and outpatient facilities, and behavioral healthcare facilities. Its segments include acute care hospital services, behavioral health care services, and Other. It owns and operates approximately 360 inpatient facilities and 48 outpatient and other facilities located in 39 states, Washington, D.C., the United Kingdom, and Puerto Rico. It provides services, which include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. It also provides capital resources, as well as a variety of management services to its facilities, including information services, finance and control systems, facilities planning, physician recruitment services, and public relations.

UHS stock is predicted to reach $250 by 2030, driven by expanding healthcare services and revenue growth in acute care and behavioral health segments. The stock's current momentum, supported by strong Q3 2024 results and new hospital openings, positions it for long-term appreciation.

UHS has a total of 73350 employees.